Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bloomfield

Showing results (391-400 of 583) with videos related to

Pageof 59
Sort By:
Cancer Research|May 3, 2008
Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemiaBjörn Hackanson, Kristi L Bennett, Romulo M Brena, et al.
Blood|April 27, 2011
Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemiaMarc Buyse, Pierre Squifflet, Beverly J Lange, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B studyJ L Slack, D C Arthur, D Lawrence, et al.
Blood|May 4, 2006
Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B studyMichael D Radmacher, Guido Marcucci, Amy S Ruppert, et al.
Molecular Cancer Therapeutics|June 6, 2019
Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid LeukemiaDimitrios Papaioannou, Deedra Nicolet, Hatice G Ozer, et al.
Journal of Oncology Practice|September 23, 2010
Benchmarks in clinical productivity: a national comprehensive cancer network surveyF Marc Stewart, Robert L Wasserman, Clara D Bloomfield, et al.
International Journal of Oncology|June 18, 2004
Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B studySherif S Farag, Amy S Ruppert, Krzysztof Mrózek, et al.
Blood|August 26, 1998
A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111R A Larson, R K Dodge, C A Linker, et al.
Oncotarget|February 14, 2018
Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemiaApollinaire Ngankeu, Parvathi Ranganathan, Violaine Havelange, et al.
Blood|June 21, 2008
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplicationSusan P Whitman, Björn Hackanson, Sandya Liyanarachchi, et al.
Pageof 59

Showing results (391-400 of 583) with videos related to

Sort By:
Pageof 59
Cancer Research|May 3, 2008
Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemiaBjörn Hackanson, Kristi L Bennett, Romulo M Brena, et al.
Blood|April 27, 2011
Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemiaMarc Buyse, Pierre Squifflet, Beverly J Lange, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B studyJ L Slack, D C Arthur, D Lawrence, et al.
Blood|May 4, 2006
Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B studyMichael D Radmacher, Guido Marcucci, Amy S Ruppert, et al.
Molecular Cancer Therapeutics|June 6, 2019
Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid LeukemiaDimitrios Papaioannou, Deedra Nicolet, Hatice G Ozer, et al.
Journal of Oncology Practice|September 23, 2010
Benchmarks in clinical productivity: a national comprehensive cancer network surveyF Marc Stewart, Robert L Wasserman, Clara D Bloomfield, et al.
International Journal of Oncology|June 18, 2004
Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B studySherif S Farag, Amy S Ruppert, Krzysztof Mrózek, et al.
Blood|August 26, 1998
A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111R A Larson, R K Dodge, C A Linker, et al.
Oncotarget|February 14, 2018
Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemiaApollinaire Ngankeu, Parvathi Ranganathan, Violaine Havelange, et al.
Blood|June 21, 2008
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplicationSusan P Whitman, Björn Hackanson, Sandya Liyanarachchi, et al.
Pageof 59